PL EN


Preferences help
enabled [disable] Abstract
Number of results
2018 | 65 | 1 | 35-41
Article title

Antidiabetic cataract effects of GbE, rutin and quercetin are mediated by the inhibition of oxidative stress and polyol pathway

Content
Title variants
Languages of publication
EN
Abstracts
EN
One of the earliest critical secondary complications of diabetes is the opacification of the eye lens - a condition strictly associated with diabetic cataract. The study presented here was designed to investigate the effect of Ginkgo biloba extract (GbE), rutin and quercetin on streptozotocin (STZ) induced diabetic cataract (DC) rats. Ten weeks after administration of GbE, rutin and quercetin, the opacity of diabetic rats' lenses was graded under a slit lamp. Then, the levels of malondialdehyde (MDA), reduced glutathione (GSH), advanced glycosylation end products (AGEs), and the activities of aldose reductase (AR) were estimated. The DC-induced rats produced less GSH, higher levels of MDA and AGEs as well as elevated AR activity when compared to the normal group. Administration of GbE, rutin and quercetin remarkably inhibited the AR activity, stimulated the production of glutathione, and decreased the levels of MDA and AGEs in the lenses of DC-induced rats, which eventually delayed the progression of lens opacification in diabetic rats to various degrees. Our results revealed that quercetin had the highest significant (P<0.05) potential to delay the progression of STZ-induced diabetic cataract when compared with rutin and GbE. The mechanism dictating this interesting prowess of quercetin might be attributed to its AR inhibitory strength, anti-lipid peroxidation potential and anti-AGEs activity.
Publisher

Year
Volume
65
Issue
1
Pages
35-41
Physical description
Dates
published
2018
received
2016-07-07
revised
2017-04-20
accepted
2017-07-11
(unknown)
2017-12-28
Contributors
author
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou 221004 China
author
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou 221004 China
author
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou 221004 China
author
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou 221004 China
author
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou 221004 China
author
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou 221004 China
author
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou 221004 China
author
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou 221004 China
author
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical College, Xuzhou 221004 China
References
  • Arnal E, Miranda M, Almansa I, Muriach M, Barcia JM, Romero FJ, Diaz-Llopis M, Bosch-Morell F (2009) Lutein prevents cataract development and progression in diabetic rats. Graefe's Archive for Clinical and Experimental Ophthalmology 247: 115-120. doi: 10.1007/s00417-008-0935-z.
  • Aronson D (2008) Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol 45: 1-16. doi: 10.1159/000115118.
  • Bahmani F, Athaie SZ, Aldavood SJ, Ghahghaei A (2012) Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats. Molecular Vision 18: 439.
  • Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
  • Bockelbrink A, Roll S, Ruether K, Rasch A, Greiner W, Willich SN (2008) Cataract surgery and the development or progression of age-related macular degeneration: a systematic review. Surv Ophthalmol 53: 359-367. doi: 10.1016/j.survophthal.2008.04.001.
  • Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820. doi: 10.1038/414813a.
  • Chan PC, Xia Q, Fu PP (2007) Ginkgo biloba leave extract: biological, medicinal, and toxicological effects. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 25: 211-244. doi: 10.1080/10590500701569414.
  • Drel VR, Pacher P, Ali TK, Shin J, Julius U, El-Remessy AB, Obrosova IG (2008) Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis. Int J Mol Med 21: 667-676.
  • Durukan AH, Evereklioglu C, Hurmeric V, Kerimoglu H, Erdurman C, Bayraktar MZ, Mumcuoglu TJ (2006) Cataract. Ingestion of IH636 grape seed proanthocyanidin extract to prevent selenite-induced oxidative stress in experimental cataract. J Cataract Refract Surg 32: 1041-1045. doi: 10.1016/j.jcrs.2006.02.041.
  • Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77.
  • Gabbay KH (1973) The sorbitol pathway and the complications of diabetes. New Engl J Med 288: 831-836. doi: 10.1056/NEJM197304192881609.
  • Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107: 1058-1070. doi: 10.1161/CIRCRESAHA.110.223545.
  • Hao HH, Shao ZM, Tang DQ, Lu Q, Chen X, Yin XX, Wu J, Chen W (2012) Preventive effects of rutin on the development of experimental diabetic nephropathy in rats. Life Sci 91: 959-967. doi: 10.1016/j.lfs.2012.09.003.
  • Isai M, Sakthivel M, Ramesh E, Thomas P, Geraldine P (2009) Prevention of selenite-induced cataractogenesis by rutin in Wistar rats. Molecular Vision 15: 2570.
  • Januszewski A, Alderson N, Metz T, Thorpe S, Baynes J (2003) Role of lipids in chemical modification of proteins and development of complications in diabetes. Biochem Soc Trans 31: 1413-1416. doi: 10.1042/bst0311413.
  • Kumar MS, Reddy PY, Kumar A, Surolia I, Reddy BG (2004) Effect of dicarbonyl-induced browning on alpha-crystallin chaperone-like activity: physiological significance and caveats of in vitro aggregation assays. Biochem J 379: 273-282. doi: 10.1042/BJ20031633.
  • Libondi T, Ragone R, Vincenti D, Stiuso P, Auricchio G, Colonna G (1994) In vitro cross-linking of calf lens α-crystallin by malondialdehyde. Int J Pept Protein Res 44: 342-347.
  • Liu YW, Zhu X, Yang QQ, Lu Q, Wang JY, Li HP, Wei YQ, Yin JL, Yin XX (2013) Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats. Psychopharmacology 228: 585-594. doi: 10.1007/s00213-013-3061-5.
  • Lu Q, Yin XX, Wang JY, Gao YY, Pan YM (2007) Effects of Ginkgo biloba on prevention of development of experimental diabetic nephropathy in rats. Acta Pharmacol Sin 28: 818-828. doi: 10.1111/j.1745-7254.2007.00570.x.
  • Lu Q, Yang T, Zhang M, Du L, Liu L, Zhang N, Guo H, Zhang F, Hu G, Yin X (2014) Preventative effects of Ginkgo biloba extract (EGb761) on high glucose-cultured opacity of rat lens. Phytother Res 28: 767-773. doi: 10.1002/ptr.5060.
  • Lu Q, Ji XJ, Zhou YX, Yao XQ, Liu YQ, Zhang F, Yin XX (2015a) Quercetin inhibits the mTORC1/p70S6K signaling-mediated renaltubular epithelial-mesenchymal transition and renal fibrosisin diabetic nephropathy. Pharmacol Res 99: 237–247. doi: 10.1016/j.phrs.2015.06.006.
  • Lu Q, Zuo WZ, Ji XJ, Zhou YX, Liu YQ, Yao XQ, Zhou XY, Liu YW, Zhang F, Yin XX (2015b) Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis throughAkt/mTOR signaling in diabetic nephropathy. Phytomedicine 22: 1071-1078. doi: 10.1016/j.phymed.2015.08.010.
  • Muthenna P, Akileshwari C, Saraswat M, Bhanuprakash Reddy G (2012) Inhibition of advanced glycation end-product formation on eye lens protein by rutin. Br J Nutr 107: 941-949. doi: 10.1017/S0007114511004077.
  • Nagaraj RH, Linetsky M, Stitt AW (2012) The pathogenic role of Maillard reaction in the aging eye. Amino Acids 42: 1205-1220. doi: 10.1007/s00726-010-0778-x.
  • Obrosova IG, Chung SS, Kador PF (2010) Diabetic cataracts: mechanisms and management. Diabetes Metab Res Rev 26: 172-180. doi: 10.1002/dmrr.1075.
  • Olson RJ, Mamalis N, Werner L, Apple DJ (2003) Cataract treatment in the beginning of the 21st century. Am J Ophthalmol 136: 146-154.
  • Patel CA, Divakar K, Santani D, Solanki HK, Thakkar JH (2012) Remedial prospective of Hippophae rhamnoides Linn. (Sea Buckthorn). ISRN Pharmacol 2012: 436857. doi: 10.5402/2012/436857.
  • Reddy GB, Muthenna P, Akileshwari C, Saraswat M, Petrash JM (2011) Inhibition of aldose reductase and sorbitol accumulation by dietary rutin. Curr Sci 101: 1191-1197.
  • Shetty A, Rashmi R, Rajan M, Sambaiah K, Salimath P (2004) Anti-diabetic influence of quercetin in streptozotocin-induced diabetic rats. Nutr Res 24: 373-381.
  • Srinivas M (2014) Delivery of glutathione to the lens nucleus. J Ophthalmic Vis Res 9: 148-149.
  • Stefek M (2011) Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdiscip Toxicol 4: 69-77. doi: 10.2478/v10102-011-0013-y.
  • Stitt AW, Jenkins AJ, Cooper ME (2002) Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs 11: 1205-1223. doi: 10.1517/13543784.11.9.1205.
  • Sun W, Oates PJ, Coutcher JB, Gerhardinger C, Lorenzi M (2006) A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes 55: 2757-2762. doi: 10.2337/db06-0138.
  • Tang WH, Martin KA, Hwa J (2012) Aldose reductase, oxidative stress, and diabetic mellitus. Front Pharmacol 3: 87. doi: 10.3389/fphar.2012.00087.
  • Tukozkan N, Eradmar H, Seven I (2006) Measurement of total malondialdehyde in plasma and tissues by high-performance liquid chromatography and thiobarbituric acid assay. Firat Tip Dergisi 11: 88-92.
  • Wang X, Xu Z, Zhao S (2005) Determination of quercetin and rutin in Ginkgo biloba extract by supercritical fluid chromatography. Chinese J Pharmaceuticals 36: 415-417.
  • Wong T, Loon S, Saw S (2006) The epidemiology of age related eye diseases in Asia. Br J Ophthalmol 90: 506-511. doi: 10.1136/bjo.2005.083733.
  • Wu ZM, Yin XX, Ji L, Gao YY, Pan YM, Lu Q, Wang JY (2008) Ginkgo biloba extract prevents against apoptosis induced by high glucose in human lens epithelial cells. Acta Pharmacol Sin 29: 1042. doi: 10.1111/j.1745-7254.2008.00837.x.
  • Yonekura H, Yamamoto Y, Sakurai S, Watanabe T, Yamamoto H (2005) Roles of the receptor for advanced glycation end products in diabetes-induced vascular injury. J Pharmacol Sci 97: 305-311. doi: 10.1042/BJ20021371.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv65p35kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.